Medicine & Life Sciences
Cyclophosphamide
100%
Graft vs Host Disease
67%
Transplantation
56%
Bone Marrow
51%
Haploidentical Transplantation
42%
Multiple Myeloma
39%
Homologous Transplantation
36%
Transplants
35%
Bone Marrow Transplantation
30%
Survival
28%
Tissue Donors
28%
Confidence Intervals
23%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22%
Recurrence
20%
Peripheral Blood Stem Cell Transplantation
18%
Aplastic Anaemia
18%
Cytokine Release Syndrome
16%
bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine
13%
Lymphoma
13%
Segmental glomerulosclerosis
13%
daratumumab
13%
Gallium-68
13%
AIDS-Associated Nephropathy
12%
Incidence
12%
Mortality
12%
Progression-Free Survival
11%
B-Lymphocytes
11%
Central Nervous System
11%
SARS Virus
11%
Whole-Body Irradiation
10%
Acute Myeloid Leukemia
10%
Deep Learning
10%
Peripheral T-Cell Lymphoma
10%
Thrombotic Microangiopathies
10%
Chimeric Antigen Receptors
10%
Lenalidomide
10%
Immunoglobulin Heavy Chains
9%
Hematologic Neoplasms
9%
Drug Therapy
9%
Primary Myelofibrosis
9%
Acute Promyelocytic Leukemia
9%
Vaccines
9%
Histocompatibility
9%
Allografts
8%
B-Cell Chronic Lymphocytic Leukemia
8%
Immunosuppression
8%
Cytochrome P-450 CYP3A
8%
Nephrons
8%
Rituximab
8%
Unrelated Donors
8%